+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Organ & Bionics Market by Product, Application, Technology, End User - Global Forecast to 2030- Product Image
Artificial Organ & Bionics Market by Product, Application, Technology, End User - Global Forecast to 2030- Product Image
Sale

Artificial Organ & Bionics Market by Product, Application, Technology, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337470
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Artificial Organ & Bionics Market grew from USD 25.45 billion in 2024 to USD 27.82 billion in 2025. It is expected to continue growing at a CAGR of 9.13%, reaching USD 43.01 billion by 2030.

Setting the Stage for Organ Replacement Revolution

The convergence of medical necessity and technological ingenuity has propelled artificial organs and bionics to the forefront of healthcare innovation. An expanding global population confronting organ failure, chronic disease, and traumatic injury has created a pressing demand for solutions that transcend the limitations of traditional transplantation. In response, researchers and manufacturers have harnessed advances in materials science, microelectronics, and tissue engineering to develop devices that not only replace biological function but also integrate seamlessly with the human body.

This executive summary distills critical developments shaping the artificial organ and bionics landscape. It highlights the strategic inflection points that will define competitive dynamics, regulatory requirements, and clinical adoption over the coming years. Designed for decision-makers seeking clarity amidst complexity, this analysis provides a concise yet comprehensive overview of market drivers, challenges, and emerging opportunities that will inform investment and operational priorities.

Landmark Shifts Redefining the Artificial Organ Landscape

Breakthroughs in additive manufacturing and bioprinting have redefined the boundaries of what is possible, enabling the production of patient-specific implants and scaffold structures with unparalleled precision. At the same time, integration of sensor networks and smart control systems has elevated device functionality, allowing real-time monitoring and adaptive response to physiological changes. These shifts coincide with a regulatory landscape that increasingly values post-market surveillance and evidence generation, compelling developers to adopt robust clinical data strategies from inception.

Meanwhile, the patient journey is being transformed by personalized medicine initiatives, digital health platforms, and telemonitoring solutions that extend care beyond hospital walls. Collaboration between academic institutions, startups, and established medical device companies has accelerated translational research, shortening time-to-market and fostering a culture of cross-disciplinary innovation. Taken together, these pivotal shifts are orchestrating a new era in which artificial organs and bionic devices transition from conceptual breakthroughs to standardized components of mainstream care.

Assessing the Impact of 2025 US Tariff Policies

The introduction of new tariffs in 2025 targeting select imported medical components has reignited supply chain scrutiny across the artificial organ and bionics sector. Manufacturers reliant on precision electronics, specialized polymers, and proprietary sensors have faced upward pressure on input costs, prompting a reevaluation of sourcing strategies and supplier diversification. In response, some companies have accelerated the establishment of domestic production lines to mitigate exposure, while others have renegotiated long-term agreements to secure tariff-protected pricing.

Beyond cost implications, these trade measures have catalyzed a strategic shift toward localized value chains and closer engagement with national regulatory authorities. Companies exploring joint ventures with domestic partners have gained preferential access to government incentives, reducing the net impact of duties on final pricing. At the same time, the tariff environment has spurred investment in research into alternative materials and manufacturing processes that can bypass subject categorizations. This dynamic has realigned competitive positioning, favoring organizations with agile operational footprints and strong local partnerships.

Insights from Multidimensional Segmentation Analysis

A multidimensional segmentation lens reveals nuanced performance across product categories. Within the artificial heart arena, total artificial heart implants exhibit high entry barriers due to complex engineering and surgical protocols, whereas ventricular assist devices enjoy broader adoption driven by shorter development cycles. In renal support, hemodialysis devices dominate established markets, while peritoneal dialysis systems gain traction in homecare settings due to their portability and patient autonomy. The artificial liver segment is characterized by rapid innovation in bioartificial liver supports, contrasted with slower uptake of extracorporeal liver assist devices constrained by resource-intensive operation. Advancements in bionic limbs have accelerated growth across hand, foot, lower limb, and upper limb applications, each benefiting from enhanced actuator miniaturization and sensor-driven feedback. Neural prosthesis developments in cochlear implants, deep brain stimulators, and retinal implants underscore the convergence of neuroscience and engineering.

Application segmentation highlights sustained momentum in cardiovascular interventions, supported by aging demographics and elevated prevalence of heart disease. Hepatic applications mirror investments in chronic liver disease management, while neurological treatments expand to encompass movement disorders and sensory restoration. Orthopedic and renal segments benefit from incremental improvements that reduce complications and streamline clinical workflows. Technology insights indicate that bioartificial organs are gaining ground through hybrid cell-scaffold constructs, mechanical organs sustain a foundation in proven reliability, and tissue engineering innovations promise long-term integration and reduced rejection. Finally, end-user segmentation underscores that hospitals remain the primary adoption channel, ambulatory surgical centers drive cost efficiencies for select procedures, specialty clinics enable niche expertise, and homecare environments unlock patient-centric care pathways.

Regional Dynamics Highlighting Global Growth Patterns

Examining regional dynamics reveals differentiated growth trajectories and strategic priorities. In the Americas, strong reimbursement frameworks and established reimbursement codes facilitate rapid adoption of next-generation devices, while extensive clinical trial networks expedite regulatory approvals. The region’s robust biomedical ecosystem continues to attract venture capital, underpinning a pipeline of early-stage innovations. In Europe, Middle East & Africa, policy harmonization initiatives and centralized health technology assessments are shaping access strategies, compelling manufacturers to compile rigorous health economics data. Collaborative projects between academic consortia and industry players are particularly vibrant in Western Europe.

The Asia-Pacific region stands out for its accelerated market expansion, driven by increasing healthcare spending, demographic shifts, and government initiatives to bolster domestic manufacturing capacity. Public-private partnerships in Japan and China have accelerated development of biocompatible materials and 3D-printed scaffolds. Regulatory bodies across Southeast Asia are adopting expedited pathways for breakthrough technologies, creating fertile ground for pilot deployments. This tri-regional overview underscores the necessity of tailoring market entry and commercialization tactics to distinct regulatory, economic, and healthcare delivery environments.

Strategic Moves and Profiles of Leading Market Players

Leading participants are deploying diverse strategies to secure market advantage. One major device manufacturer has expanded its portfolio with the acquisition of a pioneering bioartificial liver support company, leveraging its global distribution network to accelerate penetration in emerging markets. Another competitor has forged licensing agreements with academic bioreactor developers to integrate living cells into advanced organ scaffolds, establishing a foothold in high-margin, research-driven segments. In the ventricular assist device space, a well-capitalized supplier has invested heavily in miniaturization and wireless telemetry, setting new benchmarks for patient quality of life and remote monitoring capabilities.

Strategic alliances are also proliferating between bionic limb innovators and rehabilitation centers, which co-develop training protocols that enhance device acceptance and functional outcomes. Neural prosthesis leaders are channeling resources into deep brain stimulation trials for novel indications, while forging partnerships with software firms to refine closed-loop control systems. Across the board, successful organizations are distinguished by vertically integrated manufacturing, proactive regulatory engagement, and a balanced mix of organic R&D with targeted acquisitions. These moves not only expand technological breadth but also fortify geographic coverage, creating resilient platforms for sustained growth.

Actionable Strategies for Competitive Advantage

Industry leaders should prioritize the development of flexible manufacturing footprints that can pivot in response to evolving tariff and trade landscapes. Establishing joint ventures with local partners offers dual benefits of market access and reduced regulatory friction. At the same time, cultivating a strong pipeline of intellectual property around novel materials, control algorithms, and patient-specific design tools will create sustainable competitive moats.

Furthermore, embedding digital health capabilities into device offerings-ranging from predictive maintenance alerts to integrated telemonitoring-can enhance clinical value propositions and strengthen payer negotiations. Proactive engagement with regulatory bodies through pilot programs and adaptive trial designs will accelerate time-to-approval while ensuring compliance. Finally, building multidisciplinary collaborations across academic institutions, clinical centers, and patient advocacy groups will yield insights that inform product iteration and commercial strategy. By aligning operational agility with patient-centric innovation, companies can capture emerging opportunities and mitigate systemic risks.

Rigorous Methodology Underpinning the Analysis

This analysis is underpinned by a rigorous, multi-phased methodology combining primary research with exhaustive secondary data gathering. Expert interviews were conducted with leading surgeons, biomedical engineers, and regulatory advisors to capture frontline perspectives on technological feasibility and clinical adoption. An extensive review of peer-reviewed journals, patent filings, company disclosures, and government publications provided a robust quantitative foundation.

Data triangulation techniques were employed to reconcile discrepancies across sources, while validation workshops with industry stakeholders refined key assumptions. The resulting insights were stress-tested against alternative scenarios to ensure resilience. Throughout the process, quality control protocols-spanning peer review, editorial oversight, and statistical verification-guaranteed the accuracy and relevance of findings. This methodological framework ensures that the conclusions drawn are both defensible and directly actionable for decision-makers.

Concluding Perspectives on Market Evolution

The artificial organ and bionics market stands at an inflection point driven by technological maturation, regulatory evolution, and shifting patient expectations. While the path to ubiquitous adoption remains complex, the momentum generated by additive manufacturing, biofabrication, and smart device integration offers a compelling roadmap for the next decade. Companies that combine operational dexterity with deep collaboration across the value chain will be best positioned to translate scientific breakthroughs into clinical reality.

As competition intensifies and funding landscapes evolve, precision in strategic investments and regulatory planning will determine market leadership. By internalizing the insights presented-ranging from segmentation nuances to regional dynamics-industry participants can navigate uncertainty and capitalize on transformative trends. The overarching imperative is clear: embrace innovation with discipline, align product development with end-user needs, and maintain agility in the face of geopolitical and economic shifts.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product
    • Artificial Heart
      • Total Artificial Heart
      • Ventricular Assist Device
    • Artificial Kidney
      • Hemodialysis Device
      • Peritoneal Dialysis Device
    • Artificial Liver
      • Bioartificial Liver Support
      • Extracorporeal Liver Assist Device
    • Bionic Limb
      • Foot
      • Hand
      • Lower Limb
      • Upper Limb
    • Neural Prosthesis
      • Cochlear Implant
      • Deep Brain Stimulator
      • Retinal Implant
  • Application
    • Cardiovascular
    • Hepatic
    • Neurological
    • Orthopedic
    • Renal
  • Technology
    • Bioartificial Organs
    • Mechanical Organs
    • Tissue Engineering Organs
  • End User
    • Ambulatory Surgical Centers
    • Homecare
    • Hospitals
    • Specialty Clinics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Cochlear Limited
  • Össur hf.
  • Ottobock SE & Co. KGaA
  • SynCardia Systems, LLC
  • Carmat SA

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Artificial Organ & Bionics Market, by Product
8.1. Introduction
8.2. Artificial Heart
8.2.1. Total Artificial Heart
8.2.2. Ventricular Assist Device
8.3. Artificial Kidney
8.3.1. Hemodialysis Device
8.3.2. Peritoneal Dialysis Device
8.4. Artificial Liver
8.4.1. Bioartificial Liver Support
8.4.2. Extracorporeal Liver Assist Device
8.5. Bionic Limb
8.5.1. Foot
8.5.2. Hand
8.5.3. Lower Limb
8.5.4. Upper Limb
8.6. Neural Prosthesis
8.6.1. Cochlear Implant
8.6.2. Deep Brain Stimulator
8.6.3. Retinal Implant
9. Artificial Organ & Bionics Market, by Application
9.1. Introduction
9.2. Cardiovascular
9.3. Hepatic
9.4. Neurological
9.5. Orthopedic
9.6. Renal
10. Artificial Organ & Bionics Market, by Technology
10.1. Introduction
10.2. Bioartificial Organs
10.3. Mechanical Organs
10.4. Tissue Engineering Organs
11. Artificial Organ & Bionics Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Homecare
11.4. Hospitals
11.5. Specialty Clinics
12. Americas Artificial Organ & Bionics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Artificial Organ & Bionics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Artificial Organ & Bionics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Medtronic plc
15.3.2. Abbott Laboratories
15.3.3. Boston Scientific Corporation
15.3.4. Edwards Lifesciences Corporation
15.3.5. Fresenius Medical Care AG & Co. KGaA
15.3.6. Cochlear Limited
15.3.7. Össur hf.
15.3.8. Ottobock SE & Co. KGaA
15.3.9. SynCardia Systems, LLC
15.3.10. Carmat SA
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ARTIFICIAL ORGAN & BIONICS MARKET MULTI-CURRENCY
FIGURE 2. ARTIFICIAL ORGAN & BIONICS MARKET MULTI-LANGUAGE
FIGURE 3. ARTIFICIAL ORGAN & BIONICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ARTIFICIAL ORGAN & BIONICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ARTIFICIAL ORGAN & BIONICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ARTIFICIAL ORGAN & BIONICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEMODIALYSIS DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PERITONEAL DIALYSIS DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOARTIFICIAL LIVER SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY EXTRACORPOREAL LIVER ASSIST DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FOOT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HAND, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY UPPER LIMB, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COCHLEAR IMPLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DEEP BRAIN STIMULATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY RETINAL IMPLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEPATIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY RENAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOARTIFICIAL ORGANS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MECHANICAL ORGANS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TISSUE ENGINEERING ORGANS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 67. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 68. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 69. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 70. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 71. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 76. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 77. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 78. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 79. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 80. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. GERMANY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. GERMANY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 122. GERMANY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 123. GERMANY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 124. GERMANY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 125. GERMANY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 126. GERMANY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. GERMANY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. GERMANY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. FRANCE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. FRANCE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 131. FRANCE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 132. FRANCE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 133. FRANCE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 134. FRANCE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 135. FRANCE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. FRANCE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. FRANCE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. ITALY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. ITALY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 149. ITALY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 150. ITALY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 151. ITALY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 152. ITALY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 153. ITALY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. ITALY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. ITALY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. SPAIN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. SPAIN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 158. SPAIN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 159. SPAIN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 160. SPAIN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 161. SPAIN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 162. SPAIN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SPAIN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. SPAIN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. DENMARK ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. DENMARK ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 194. DENMARK ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 195. DENMARK ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 196. DENMARK ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 197. DENMARK ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 198. DENMARK ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. DENMARK ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. DENMARK ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. QATAR ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. QATAR ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 212. QATAR ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 213. QATAR ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 214. QATAR ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 215. QATAR ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 216. QATAR ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. QATAR ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 218. QATAR ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. FINLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. FINLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 221. FINLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 222. FINLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 223. FINLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 224. FINLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 225. FINLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. FINLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. FINLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. EGYPT ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 247. EGYPT ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 248. EGYPT ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 249. EGYPT ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 250. EGYPT ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 251. EGYPT ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 252. EGYPT ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. EGYPT ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. EGYPT ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. TURKEY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 256. TURKEY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 257. TURKEY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 258. TURKEY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 259. TURKEY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 260. TURKEY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 261. TURKEY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. TURKEY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 263. TURKEY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. NORWAY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 274. NORWAY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 275. NORWAY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 276. NORWAY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 277. NORWAY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 278. NORWAY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 279. NORWAY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. NORWAY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. NORWAY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. POLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 283. POLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 284. POLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 285. POLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 286. POLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 287. POLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 288. POLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. POLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 290. POLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 308. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 310. CHINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 311. CHINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL HEART, 2018-2030 (USD MILLION)
TABLE 312. CHINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 313. CHINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 314. CHINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMB, 2018-2030 (USD MILLION)
TABLE 315. CHINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY NEURAL PROSTHESIS, 2018-2030 (USD MILLION)
TABLE 316. CHINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 317. CHINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 318. CHINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. INDIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 320. INDIA ARTIFICIAL OR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Artificial Organ & Bionics market report include:
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Cochlear Limited
  • Össur hf.
  • Ottobock SE & Co. KGaA
  • SynCardia Systems, LLC
  • Carmat SA

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 27.82 Billion
Forecasted Market Value ( USD ) by 2030 $ 43.01 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Artificial Vital Organs And Medical Bionics Market Size, Share & Trends Analysis Report By Artificial Organs (Heart, Kidney, Liver), By Bionics (Ear Bionics, Vision Bionics, Exoskeletons), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Artificial Vital Organs And Medical Bionics Market Size, Share & Trends Analysis Report By Artificial Organs (Heart, Kidney, Liver), By Bionics (Ear Bionics, Vision Bionics, Exoskeletons), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Artificial Vital Organs and Medical Bionics Market Report by Product Type, Application, and Region 2024-2032 - Product Image

Artificial Vital Organs and Medical Bionics Market Report by Product Type, Application, and Region 2024-2032

  • Report
  • 142 Pages
  • Global
From
Artificial Organs and Bionics - Global Strategic Business Report - Product Image

Artificial Organs and Bionics - Global Strategic Business Report

  • Report
  • 129 Pages
  • Global
From
Wearable Artificial Organs Market Size, Share & Trends Analysis Report By Artificial Organ (Kidney, Pancreas, Cochlear Implant, Exoskeleton, Bionic Limbs, Brain Bionics, Vision Bionics), By Technology, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Wearable Artificial Organs Market Size, Share & Trends Analysis Report By Artificial Organ (Kidney, Pancreas, Cochlear Implant, Exoskeleton, Bionic Limbs, Brain Bionics, Vision Bionics), By Technology, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 110 Pages
  • Global
From
Medical Bionic Implant/Artificial Organs Market Report 2025 - Product Image

Medical Bionic Implant/Artificial Organs Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.